Global Depressive Disorder Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2024

Published On: April 2019 | Report ID: 160924 | Category: Pharmaceuticals and HealthcarePages: 115

Depression includes a variety of mental health problems characterized by the absence of a positive emotion, low mood, and a range of associated cognitive, physical, emotional, and behavioral symptoms. It is a very common condition that affects 1 in every 5 Americans. There are many factors including genes, factors such as stress and brain chemistry that could lead to depression.

Scope of the Report:

The Depressive Disorder market will undergo a period of steady growth from 2015 to 2025, mainly attributed to the growth in atypical antipsychotics and the expected launch of five pipeline.

The global Depressive Disorder market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Depressive Disorder.

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

This report studies the Depressive Disorder market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Depressive Disorder market by product type and applications/end industries.

Market Segment by Companies, this report covers

Alkermes

Allergan

Bristol Myers Squibb

Eli Lilly

Glaxosmithkline

H. Lundbeck

Merck

Pfizer

Teva Pharmaceutical

Takeda Pharmaceutical

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Tricyclic Antidepressants

Selective Serotonin Reuptake Inhibitors

Serotonin-Norepinephrine Reuptake Inhibitors

Monoamine Oxidase Inhibitors

Serotonin Antagonist And Reuptake Inhibitors

Others

Market Segment by Applications, can be divided into

Hospitals

Ambulatory Surgical Centers

Diagnostic Centers

Homecare Settings

Long Term Care Centers

Table of Contents

1 Depressive Disorder Market Overview

1.1 Product Overview and Scope of Depressive Disorder

1.2 Classification of Depressive Disorder by Types

1.2.1 Global Depressive Disorder Revenue Comparison by Types (2017-2023)

1.2.2 Global Depressive Disorder Revenue Market Share by Types in 2017

1.2.3 Tricyclic Antidepressants

1.2.4 Selective Serotonin Reuptake Inhibitors

1.2.5 Serotonin-Norepinephrine Reuptake Inhibitors

1.2.6 Monoamine Oxidase Inhibitors

1.2.7 Serotonin Antagonist And Reuptake Inhibitors

1.2.8 Others

1.3 Global Depressive Disorder Market by Application

1.3.1 Global Depressive Disorder Market Size and Market Share Comparison by Applications (2013-2023)

1.3.2 Hospitals

1.3.3 Ambulatory Surgical Centers

1.3.4 Diagnostic Centers

1.3.5 Homecare Settings

1.3.6 Long Term Care Centers

1.4 Global Depressive Disorder Market by Regions

1.4.1 Global Depressive Disorder Market Size (Million USD) Comparison by Regions (2013-2023)

1.4.1 North America (USA, Canada and Mexico) Depressive Disorder Status and Prospect (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy) Depressive Disorder Status and Prospect (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Depressive Disorder Status and Prospect (2013-2023)

1.4.4 South America (Brazil, Argentina, Colombia) Depressive Disorder Status and Prospect (2013-2023)

1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Depressive Disorder Status and Prospect (2013-2023)

1.5 Global Market Size of Depressive Disorder (2013-2023)

2 Manufacturers Profiles

2.1 Alkermes

2.1.1 Business Overview

2.1.2 Depressive Disorder Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Alkermes Depressive Disorder Revenue, Gross Margin and Market Share (2016-2017)

2.2 Allergan

2.2.1 Business Overview

2.2.2 Depressive Disorder Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Allergan Depressive Disorder Revenue, Gross Margin and Market Share (2016-2017)

2.3 Bristol Myers Squibb

2.3.1 Business Overview

2.3.2 Depressive Disorder Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Bristol Myers Squibb Depressive Disorder Revenue, Gross Margin and Market Share (2016-2017)

2.4 Eli Lilly

2.4.1 Business Overview

2.4.2 Depressive Disorder Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Eli Lilly Depressive Disorder Revenue, Gross Margin and Market Share (2016-2017)

2.5 Glaxosmithkline

2.5.1 Business Overview

2.5.2 Depressive Disorder Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Glaxosmithkline Depressive Disorder Revenue, Gross Margin and Market Share (2016-2017)

2.6 H. Lundbeck

2.6.1 Business Overview

2.6.2 Depressive Disorder Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 H. Lundbeck Depressive Disorder Revenue, Gross Margin and Market Share (2016-2017)

2.7 Merck

2.7.1 Business Overview

2.7.2 Depressive Disorder Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Merck Depressive Disorder Revenue, Gross Margin and Market Share (2016-2017)

2.8 Pfizer

2.8.1 Business Overview

2.8.2 Depressive Disorder Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Pfizer Depressive Disorder Revenue, Gross Margin and Market Share (2016-2017)

2.9 Teva Pharmaceutical

2.9.1 Business Overview

2.9.2 Depressive Disorder Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 Teva Pharmaceutical Depressive Disorder Revenue, Gross Margin and Market Share (2016-2017)

2.10 Takeda Pharmaceutical

2.10.1 Business Overview

2.10.2 Depressive Disorder Type and Applications

2.10.2.1 Product A

2.10.2.2 Product B

2.10.3 Takeda Pharmaceutical Depressive Disorder Revenue, Gross Margin and Market Share (2016-2017)

3 Global Depressive Disorder Market Competition, by Players

3.1 Global Depressive Disorder Revenue and Share by Players (2013-2018)

3.2 Market Concentration Rate

3.2.1 Top 5 Depressive Disorder Players Market Share

3.2.2 Top 10 Depressive Disorder Players Market Share

3.3 Market Competition Trend

4 Global Depressive Disorder Market Size by Regions

4.1 Global Depressive Disorder Revenue and Market Share by Regions

4.2 North America Depressive Disorder Revenue and Growth Rate (2013-2018)

4.3 Europe Depressive Disorder Revenue and Growth Rate (2013-2018)

4.4 Asia-Pacific Depressive Disorder Revenue and Growth Rate (2013-2018)

4.5 South America Depressive Disorder Revenue and Growth Rate (2013-2018)

4.6 Middle East and Africa Depressive Disorder Revenue and Growth Rate (2013-2018)

5 North America Depressive Disorder Revenue by Countries

5.1 North America Depressive Disorder Revenue by Countries (2013-2018)

5.2 USA Depressive Disorder Revenue and Growth Rate (2013-2018)

5.3 Canada Depressive Disorder Revenue and Growth Rate (2013-2018)

5.4 Mexico Depressive Disorder Revenue and Growth Rate (2013-2018)

6 Europe Depressive Disorder Revenue by Countries

6.1 Europe Depressive Disorder Revenue by Countries (2013-2018)

6.2 Germany Depressive Disorder Revenue and Growth Rate (2013-2018)

6.3 UK Depressive Disorder Revenue and Growth Rate (2013-2018)

6.4 France Depressive Disorder Revenue and Growth Rate (2013-2018)

6.5 Russia Depressive Disorder Revenue and Growth Rate (2013-2018)

6.6 Italy Depressive Disorder Revenue and Growth Rate (2013-2018)

7 Asia-Pacific Depressive Disorder Revenue by Countries

7.1 Asia-Pacific Depressive Disorder Revenue by Countries (2013-2018)

7.2 China Depressive Disorder Revenue and Growth Rate (2013-2018)

7.3 Japan Depressive Disorder Revenue and Growth Rate (2013-2018)

7.4 Korea Depressive Disorder Revenue and Growth Rate (2013-2018)

7.5 India Depressive Disorder Revenue and Growth Rate (2013-2018)

7.6 Southeast Asia Depressive Disorder Revenue and Growth Rate (2013-2018)

8 South America Depressive Disorder Revenue by Countries

8.1 South America Depressive Disorder Revenue by Countries (2013-2018)

8.2 Brazil Depressive Disorder Revenue and Growth Rate (2013-2018)

8.3 Argentina Depressive Disorder Revenue and Growth Rate (2013-2018)

8.4 Colombia Depressive Disorder Revenue and Growth Rate (2013-2018)

9 Middle East and Africa Revenue Depressive Disorder by Countries

9.1 Middle East and Africa Depressive Disorder Revenue by Countries (2013-2018)

9.2 Saudi Arabia Depressive Disorder Revenue and Growth Rate (2013-2018)

9.3 UAE Depressive Disorder Revenue and Growth Rate (2013-2018)

9.4 Egypt Depressive Disorder Revenue and Growth Rate (2013-2018)

9.5 Nigeria Depressive Disorder Revenue and Growth Rate (2013-2018)

9.6 South Africa Depressive Disorder Revenue and Growth Rate (2013-2018)

10 Global Depressive Disorder Market Segment by Type

10.1 Global Depressive Disorder Revenue and Market Share by Type (2013-2018)

10.2 Global Depressive Disorder Market Forecast by Type (2018-2023)

10.3 Tricyclic Antidepressants Revenue Growth Rate (2013-2023)

10.4 Selective Serotonin Reuptake Inhibitors Revenue Growth Rate (2013-2023)

10.5 Serotonin-Norepinephrine Reuptake Inhibitors Revenue Growth Rate (2013-2023)

10.6 Monoamine Oxidase Inhibitors Revenue Growth Rate (2013-2023)

10.7 Serotonin Antagonist And Reuptake Inhibitors Revenue Growth Rate (2013-2023)

10.8 Others Revenue Growth Rate (2013-2023)

11 Global Depressive Disorder Market Segment by Application

11.1 Global Depressive Disorder Revenue Market Share by Application (2013-2018)

11.2 Depressive Disorder Market Forecast by Application (2018-2023)

11.3 Hospitals Revenue Growth (2013-2018)

11.4 Ambulatory Surgical Centers Revenue Growth (2013-2018)

11.5 Diagnostic Centers Revenue Growth (2013-2018)

11.6 Homecare Settings Revenue Growth (2013-2018)

11.7 Long Term Care Centers Revenue Growth (2013-2018)

12 Global Depressive Disorder Market Size Forecast (2018-2023)

12.1 Global Depressive Disorder Market Size Forecast (2018-2023)

12.2 Global Depressive Disorder Market Forecast by Regions (2018-2023)

12.3 North America Depressive Disorder Revenue Market Forecast (2018-2023)

12.4 Europe Depressive Disorder Revenue Market Forecast (2018-2023)

12.5 Asia-Pacific Depressive Disorder Revenue Market Forecast (2018-2023)

12.6 South America Depressive Disorder Revenue Market Forecast (2018-2023)

12.7 Middle East and Africa Depressive Disorder Revenue Market Forecast (2018-2023)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Data Source

Please fill the form below, to recieve the report sample

Name*
Email*
Phone*
Name of the Company*
Title / Designation*
Country*
Your specific requirements*
Human Verification*

Please fill the form below for enquiry

Name*
Email*
Phone*
Name of the Company*
Title / Designation*
Country*
Your specific requirements*
Human Verification*
Choose License Type



Why Choose Us

  24/7 Research support

Get your queries resolved from an industry expert. Request for a free product review before report purchase.

Email: sales@mrinsights.biz

  Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

  Information security

Your personal and confidential information is safe and secure.